Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 10 of 10 for “"Fatostatin"”.

  1. A Lipidomics-Based Approach to Study Fatostatin-Induced Toxicity

    … of many types of cancer. The small molecule fatostatin, which downregulates fatty acid biosynthesis through inhibition of a key transcription factor, has thus become the subject of many research investigations due to its potential as a widely effective cancer therapeutic agent. Through these …

    buffalo Repository record for A Lipidomics-Based Approach to Study Fatostatin-Induced Toxicity (opens in a new tab)

  2. THE ROLE OF STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) IN KIDNEY FIBROSIS

    … independent and dependent manner.</p> <p>We used fatostatin, a SCAP inhibitor, to reduce the amount of active SREBP in animals in the unilateral ureter obstruction (UUO) model. This model is well known for its development of TIF. Fatostatin decreased SREBP-1 and SREBP-2 activation in mice after 7 …

    mcmaster Repository record for THE ROLE OF STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) IN KIDNEY FIBROSIS (opens in a new tab)

  3. Therapeutic targeting of high-fat diet-induced metabolic and Myc signalling pathways through novel drug combinations in neuroblastoma

    … was partially MYCN-dependent and reversed by Fatostatin, a sterol regulatory element-binding protein 1 (SREBP1)-mediated FA metabolism inhibitor. Fatostatin showed significant synergy in combination with doxorubicin and vincristine in reversing FA-accelerated survival in MYCN-amplified NB …

    unsw Repository record for Therapeutic targeting of high-fat diet-induced metabolic and Myc signalling pathways through novel drug combinations in neuroblastoma (opens in a new tab) Embargoed

  4. Modulation of Intralocular Pressure by Tuning Transcriptional Control of Lipid Synthesis

    … TM. The pharmacological inhibition of SREBPs by fatostatin and molecular inactivation of SREBPs ex vivo and in vivo resulted in significant IOP lowering. Conversely, significantly elevated IOP was observed after using the pharmacological activator of SREBPs by clozapine and constitutive …

    iupui Repository record for Modulation of Intralocular Pressure by Tuning Transcriptional Control of Lipid Synthesis (opens in a new tab)

  5. Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Inhibitors Arrest Tumour Growth in Glioblastoma Multiforme (T98G) and Human pancreatic carcinoma (MIA PaCa-2) Cell Lines.

    … and other SREBP1 inhibitors such as PF429242 and fatostatin arrest the proliferation of cells in a well-established model of GBM cells, the T98G cell line, maintained in vitro in culture. The present study investigates the efficacy of SREBP-1 inhibitors such as fatostatin, PF429242 and a recently …

    sask Repository record for Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Inhibitors Arrest Tumour Growth in Glioblastoma Multiforme (T98G) and Human pancreatic carcinoma (MIA PaCa-2) Cell Lines. (opens in a new tab)

  6. SREBP-1 and Cell Surface GRP78 are important modulators of TGF-β1 in the progression of diabetic nephropathy

    … inhibition of SREBP in vivo with the inhibitor fatostatin may prevent diabetic nephropathy. Our results indicate that treatment with fatostatin does not prevent diabetic nephropathy, but accentuates kidney injury in non-diabetic mice. Preliminary results from our lab have indicated that under …

    mcmaster Repository record for SREBP-1 and Cell Surface GRP78 are important modulators of TGF-β1 in the progression of diabetic nephropathy (opens in a new tab)

  7. Combined Inhibition of SREBP and m-TORC1 Signaling Synergistically Inhibits the Proliferation of B Cell Lymphoma

    … target HMG-CoA reductase (HMGCR) using Fatostatin or Simvastatin effectively restrains the proliferation of B cell lymphoma cells. However, B cell lymphoma cells activate the mTORC1-pS6 pathway in response to statin treatment, suggesting a possible mechanism to counteract statin-induced …

    iupui Repository record for Combined Inhibition of SREBP and m-TORC1 Signaling Synergistically Inhibits the Proliferation of B Cell Lymphoma (opens in a new tab)

  8. SREBP Inhibitor, PF429242, Suppresses Proliferation of Prostate Cancer Cell Lines

    … was comparable to the similar compound, Fatostatin (mean±SEM), which was studied earlier on prostate cancer. The observed IC50 was closely similar between the two cell lines (IC50 9.6µM in LNCaP, IC50 9.8µM in C4-2). However, when the inhibitory effects of PF429242 compared to Paclitaxel …

    sask Repository record for SREBP Inhibitor, PF429242, Suppresses Proliferation of Prostate Cancer Cell Lines (opens in a new tab)

  9. THE ROLE OF SREBP-1 IN MEDIATING ANGIOTENSIN II- INDUCED KIDNEY FIBROSIS

    … level, and this induction could be block ed by Fatostatin, an SREBP/SCAP inhibitor. My data showed that ANGII could induce SREBP-1 in a time and dose dependent manner. Therefore my study focused on understanding the role of SREBP-1 in ANGII-induced TGF-ß upregulation in primary mesangial cells …

    mcmaster Repository record for THE ROLE OF SREBP-1 IN MEDIATING ANGIOTENSIN II- INDUCED KIDNEY FIBROSIS (opens in a new tab)